See more : RiseSun Real Estate Development Co.,Ltd (002146.SZ) Income Statement Analysis – Financial Results
Complete financial analysis of Mednow Inc. (MDNWF) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Mednow Inc., a leading company in the Medical – Healthcare Information Services industry within the Healthcare sector.
You may be interested
- Deep Lake Capital Acquisition Corp. (DLCAU) Income Statement Analysis – Financial Results
- Megola, Inc. (MGON) Income Statement Analysis – Financial Results
- Zhuhai CosMX Battery Co., Ltd. (688772.SS) Income Statement Analysis – Financial Results
- VPC Impact Acquisition Holdings (VIH) Income Statement Analysis – Financial Results
- SATYAM SILK MILLS LTD. (ZSATYASL.BO) Income Statement Analysis – Financial Results
Mednow Inc. (MDNWF)
About Mednow Inc.
Mednow Inc., a healthcare company, develops and operates a proprietary web and mobile application to facilitate the sale and distribution of prescription medications and the delivery of virtual care, telemedicine services, and doctor home visits in Canada. It also owns and operates retail pharmacies located in British Columbia, Manitoba, Ontario, and Nova Scotia. The company was incorporated in 2018 and is headquartered in Vancouver, Canada.
| Metric | 2022 | 2021 | 2020 |
|---|---|---|---|
| Revenue | 16.64M | 414.00K | 0.00 |
| Cost of Revenue | 13.86M | 0.00 | 0.00 |
| Gross Profit | 2.78M | 414.00K | 0.00 |
| Gross Profit Ratio | 16.73% | 100.00% | 0.00% |
| Research & Development | 0.00 | 0.00 | 0.00 |
| General & Administrative | 19.84M | 8.31M | 385.94K |
| Selling & Marketing | 2.82M | 896.51K | 83.56K |
| SG&A | 22.66M | 9.21M | 469.50K |
| Other Expenses | -19.88M | 0.00 | 0.00 |
| Operating Expenses | 2.78M | 9.41M | 469.50K |
| Cost & Expenses | 36.33M | 9.41M | 469.50K |
| Interest Income | 158.35K | 50.09K | 0.00 |
| Interest Expense | 188.51K | 815.00 | 0.00 |
| Depreciation & Amortization | 1.76M | 201.35K | 206.30K |
| EBITDA | -19.85M | -8.75M | -469.50K |
| EBITDA Ratio | -119.28% | -2,113.93% | 0.00% |
| Operating Income | -19.69M | -8.95M | -469.50K |
| Operating Income Ratio | -118.33% | -2,162.57% | 0.00% |
| Total Other Income/Expenses | -10.38M | -156.60K | 0.00 |
| Income Before Tax | -30.07M | -8.95M | -469.50K |
| Income Before Tax Ratio | -180.73% | -2,162.76% | 0.00% |
| Income Tax Expense | -515.96K | -3.71K | 0.00 |
| Net Income | -29.48M | -8.95M | -469.50K |
| Net Income Ratio | -177.20% | -2,162.76% | 0.00% |
| EPS | -1.37 | -0.49 | -0.02 |
| EPS Diluted | -1.37 | -0.49 | -0.02 |
| Weighted Avg Shares Out | 21.57M | 18.40M | 21.60M |
| Weighted Avg Shares Out (Dil) | 21.57M | 18.40M | 21.60M |
Mednow Announces Closing of Senior Secured Convertible Debenture Financing by Mednow Management
VANCOUVER, British Columbia--(BUSINESS WIRE)--Mednow Inc. (TSXV: MNOW) (OTCQX: MDNWF) ("Mednow" or the "Company"), Canada's on-demand virtual pharmacy, is pleased to announce the closing of the previously announced non-brokered private placement offering of a secured convertible debenture (the “Convertible Debenture”) for...
Mednow Announces Senior Secured Convertible Debenture Financing by Mednow Management
VANCOUVER, British Columbia--(BUSINESS WIRE)--Mednow Inc. (TSXV: MNOW) (OTCQX: MDNWF) ("Mednow" or the "Company"), Canada's on-demand virtual pharmacy, is pleased to announce a private placement offering of a secured convertible debenture (the “Convertible Debenture”) for gross proceeds of $400,000 (the “Offering”)....
Mednow Inc. to Present at LD Micro Invitational XIII
TORONTO--(BUSINESS WIRE)--Mednow Inc (TSXV: MNOW) (OTCQX:MDNWF) – Mednow announced today that it will be presenting at the 13th Annual LD Micro Invitational at the Luxe Sunset Boulevard Hotel, California on June 6th-8th, 2023. The event is expected to feature 150+...
Mednow Inc. to Present at the Gravitas' 4th Los Angeles Summit
TORONTO--(BUSINESS WIRE)--Mednow Inc (TSXV: MNOW) (OTCQX:MDNWF) – Mednow is pleased to announce it will be presenting at Gravitas' 4th Los Angeles Summit, which will be taking place at The Beverly Hills Hotel from Sunday, June 4th to Tuesday, June 6th,...
Mednow Launches New Virtual Diabetes Management Program in Partnership With Dexcom
TORONTO--( BUSINESS WIRE )--Mednow Inc. (“Mednow” or the “Company”) (TSXV: MNOW) (OTCQX: MDNWF) announced today the launch of its enhanced Virtual Diabetes Management program, an end-to-end digital diabetes management solution, to enable convenient on-demand access to Dexcom G6 (NASDAQ: DXCM)...
Mednow to Host Quarterly Conference Call on Tuesday November 29, 2022, at 8:30am EST on its Fourth-Quarter 2022 Financial Results
TORONTO--( BUSINESS WIRE )--Mednow Inc. (“Mednow'' or the “Company”) (TSXV:MNOW), Canada's on-demand virtual pharmacy, is pleased to announce the Company will be hosting its quarterly conference call on Tuesday November 29, 2022 at 8:30am EST. The conference call will cover...
Mednow says it is officially open to serve patients in Quebec, with its newest location serving as its pharmacy distribution center
Mednow Inc (TSX-V:MNOW, OTCQB:MDNWF) has said it is officially open to serve patients in Quebec, with its newest location serving as the pharmacy distribution center for all Mednow customers in the province, offering fast, free prescription delivery and deep commitment...
Mednow disrupts the Canadian drug market as a virtual pharmacy and telemedicine powerhouse
The coronavirus (COVID-19) pandemic has been driving the need for accelerated innovation in healthcare and the pharmaceutical e-commerce space, in particular, has seen massive pandemic-induced growth. No other Canadian company has ridden the pandemic wave as well as health tech savvy Mednow...
Mednow subsidiary partners with non-profit company HepCURE to help eliminate hepatitis C in Canada by 2030
Mednow Inc (TSX-V:MNOW, OTCQB:MDNWF) said its Liver Care Canada subsidiary has entered into a partnership agreement with HepCURE, a non-profit company and one of Canada's leading hepatitis C screening and treatment providers, to achieve the goal of eliminating hepatitis C...
Mednow beats guidance with record 3Q results and announces Ali Reyhany as CEO
Mednow Inc (TSX-V:MNOW, OTCQB:MDNWF), Canada's on-demand virtual pharmacy, has said it achieved record third-quarter 2022 financial results, beating guidance. The company reported revenue of $6.14 million for the three months ended April 30, 2022, a 225% quarter-over-quarter improvement, which it...
Source: https://incomestatements.info
Category: Stock Reports